Celltrion’s third plant in final validation process, operation set for December
IndustryJul 23, 2024
Celltrion has begun the final validation process for its third plant in Songdo, Incheon, before commencing commercial production, the South Korean biosimilar giant announced Tuesday. The validation process is a critical step before the commercial production of drugs, which involves objectively verifying and documenting that products are manufactured to meet predefined standards from drug development to production. Celltrion invested some 270 billion won ($194 million) for the third plant's